Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.62M | -72.23M | -74.42M | -110.34M | -113.04M |
| Total Depreciation and Amortization | 115.76M | 92.78M | 95.18M | 97.34M | 96.72M |
| Total Amortization of Deferred Charges | 33.95M | 35.99M | 37.45M | 39.94M | 41.46M |
| Total Other Non-Cash Items | 70.23M | 89.49M | 98.21M | 103.62M | 95.56M |
| Change in Net Operating Assets | -116.56M | -11.65M | 19.81M | 24.89M | 21.89M |
| Cash from Operations | 18.77M | 134.38M | 176.23M | 155.47M | 142.58M |
| Capital Expenditure | -33.12M | -41.74M | -31.25M | -26.42M | -28.75M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 577.00K | 577.00K | 577.00K |
| Cash Acquisitions | -19.50M | 0.00 | 0.00 | -1.52M | -388.25M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.31M | -7.31M | -4.80M | -2.92M | 870.00K |
| Cash from Investing | -62.93M | -49.05M | -35.47M | -30.28M | -415.54M |
| Total Debt Issued | 58.58M | 391.43M | 391.43M | 391.16M | 647.49M |
| Total Debt Repaid | 0.00 | -417.23M | -427.23M | -427.23M | -464.20M |
| Issuance of Common Stock | 3.46M | 6.80M | 8.98M | 12.00M | 12.52M |
| Repurchase of Common Stock | -15.70M | -16.33M | -17.25M | -17.02M | -15.29M |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 168.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -20.09M | -20.44M | -20.40M | -20.22M | -18.79M |
| Other Financing Activities | -26.82M | -126.08M | -145.76M | -22.20M | -48.39M |
| Cash from Financing | -565.00K | -181.86M | -210.22M | -83.51M | 281.34M |
| Foreign Exchange rate Adjustments | -229.00K | -111.00K | -190.00K | -167.00K | -79.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.96M | -96.65M | -69.65M | 41.51M | 8.30M |
